Side-by-side comparison of AI visibility scores, market position, and capabilities
National aggregate (crushed stone) producer with $6.6B FY2024 revenue; permitting barriers create durable pricing power; IIJA infrastructure spending multi-year tailwind; competes with Vulcan Materials.
Martin Marietta Materials is one of the nation's leading suppliers of building materials, including aggregates (crushed stone, sand, and gravel), cement, ready-mixed concrete, and asphalt—the essential bulk commodities upon which roads, bridges, buildings, and infrastructure are built. Spun off from Martin Marietta Corporation in 1993 and headquartered in Raleigh, North Carolina, the company trades on NYSE (MLM) and generated approximately $6.6 billion in net revenues for FY2024 under CEO Ward Nye, who has led Martin Marietta since 2010 and executed a long-term geographic expansion strategy that has doubled the company's revenue and market capitalization through acquisitions and organic pricing growth. The 2022 acquisition of Lehigh Hanson's Western operations from Heidelberg Materials for $2.3 billion added major aggregate reserves in Texas and Colorado, reinforcing Martin Marietta's Sun Belt and Rocky Mountain footprint.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.